InVivoSIM anti-human TNFalpha (Adalimumab Biosimilar)
SIM0001
ApplicationsFunctional Assay, Flow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ELISA, ImmunoHistoChemistry, Neutralisation/Blocking
Product group Antibodies
ReactivityHuman
Overview
- SupplierBio X Cell
- Product NameInVivoSIM anti-human TNFalpha (Adalimumab Biosimilar)
- Delivery Days Customer7
- ApplicationsFunctional Assay, Flow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ELISA, ImmunoHistoChemistry, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDAdalimumab
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostHuman
- IsotypeIgG1
- ReactivityHuman
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Fredon M, Poussard M, Biichlé S, et al. Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells. Cancer Immunol Res. 2024,12(8):1090-1107. doi: 10.1158/2326-6066.CIR-23-0548Read this paper
- Wang F, Zhou F, Peng J, et al. Macrophage Tim-3 maintains intestinal homeostasis in DSS-induced colitis by suppressing neutrophil necroptosis. Redox Biol. 2024,70:103072. doi: 10.1016/j.redox.2024.103072Read this paper
- Jarvi NL, Balu-Iyer SV. A mechanistic marker-based screening tool to predict clinical immunogenicity of biologics. Commun Med (Lond). 2023,3(1):174. doi: 10.1038/s43856-023-00413-7Read this paper
- Müller T, Tasser C, Tesar M, et al. Selection of bispecific antibodies with optimal developability using FcRn‑Ph‑HPLC as an optimized FcRn affinity chromatography method. MAbs. 2023,15(1):2245519. doi: 10.1080/19420862.2023.2245519Read this paper
